HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuan Chen Selected Research

aumolertinib

1/2022AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations.
1/2022Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuan Chen Research Topics

Disease

213Neoplasms (Cancer)
03/2024 - 08/2003
43Inflammation (Inflammations)
03/2024 - 01/2008
37Lung Neoplasms (Lung Cancer)
03/2024 - 01/2005
36Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2024 - 01/2011
32Infections
01/2024 - 02/2010
30Neoplasm Metastasis (Metastasis)
01/2024 - 06/2012
26Breast Neoplasms (Breast Cancer)
05/2024 - 08/2009
25Colorectal Neoplasms (Colorectal Cancer)
12/2023 - 08/2005
22Pain (Aches)
05/2024 - 01/2006
21Carcinogenesis
12/2023 - 12/2012
16Hepatocellular Carcinoma (Hepatoma)
02/2024 - 04/2013
15Adenocarcinoma
01/2024 - 08/2003
15Carcinoma (Carcinomatosis)
12/2023 - 08/2003
14Cardiovascular Diseases (Cardiovascular Disease)
03/2024 - 10/2014
13Pancreatic Neoplasms (Pancreatic Cancer)
10/2023 - 01/2014
12Adenocarcinoma of Lung
02/2024 - 02/2010
12Hypoxia (Hypoxemia)
01/2024 - 05/2006
12Atherosclerosis
01/2022 - 10/2014
11Disease Progression
05/2024 - 02/2015
11Stomach Neoplasms (Stomach Cancer)
12/2023 - 03/2011
11Obesity
01/2023 - 04/2009
11Body Weight (Weight, Body)
01/2023 - 01/2008
11Prostatic Neoplasms (Prostate Cancer)
07/2022 - 02/2010
10Wounds and Injuries (Trauma)
10/2023 - 01/2018
10COVID-19
07/2023 - 01/2021
10Thymoma (Thymic Carcinoma)
01/2023 - 09/2014
9Necrosis
01/2024 - 02/2010
9Type 2 Diabetes Mellitus (MODY)
10/2022 - 07/2011
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2021 - 08/2003
8Cognitive Dysfunction
05/2024 - 01/2015
8Hypertension (High Blood Pressure)
05/2024 - 08/2012
8Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2022 - 02/2007
8Trigeminal Neuralgia (Tic Douloureux)
01/2020 - 04/2012
7Hemorrhage
01/2023 - 01/2020
7Melanoma (Melanoma, Malignant)
01/2022 - 09/2012
7Asthma (Bronchial Asthma)
12/2021 - 12/2013
7Peritonitis
01/2016 - 07/2010
6Stroke (Strokes)
05/2024 - 10/2016
6Epilepsy (Aura)
04/2024 - 05/2019
6Dyspepsia (Indigestion)
11/2023 - 05/2017
6Hyperglycemia
09/2023 - 11/2016
6Hypersensitivity (Allergy)
01/2023 - 09/2009
6Alzheimer Disease (Alzheimer's Disease)
01/2023 - 09/2011
6Osteoporosis
01/2022 - 05/2009
6Esophageal Neoplasms (Esophageal Cancer)
11/2021 - 03/2006
6Colonic Neoplasms (Colon Cancer)
06/2018 - 11/2012
5Neuroinflammatory Diseases
03/2024 - 01/2021
5Diabetes Mellitus
01/2024 - 10/2014

Drug/Important Bio-Agent (IBA)

89Proteins (Proteins, Gene)FDA Link
03/2024 - 08/2003
53Biomarkers (Surrogate Marker)IBA
05/2024 - 08/2005
32Messenger RNA (mRNA)IBA
01/2023 - 08/2003
21Therapeutic UsesIBA
03/2024 - 01/2006
20MicroRNAs (MicroRNA)IBA
11/2023 - 02/2015
18Glucose (Dextrose)FDA LinkGeneric
01/2024 - 10/2012
16DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2009
15ErbB Receptors (EGF Receptor)IBA
09/2023 - 01/2011
13RNA (Ribonucleic Acid)IBA
05/2024 - 06/2011
13Immune Checkpoint InhibitorsIBA
03/2024 - 05/2020
12CytokinesIBA
04/2024 - 01/2014
11Anti-Bacterial Agents (Antibiotics)IBA
03/2024 - 01/2014
11Insulin (Novolin)FDA Link
09/2023 - 10/2009
11Type A Botulinum Toxins (Botox)FDA Link
01/2020 - 01/2011
10EnzymesIBA
09/2023 - 02/2013
10Phosphotransferases (Kinase)IBA
05/2021 - 10/2009
9Blood Glucose (Blood Sugar)IBA
09/2023 - 04/2015
9Cisplatin (Platino)FDA LinkGeneric
04/2023 - 01/2015
9Bile Acids and Salts (Bile Acids)IBA
02/2023 - 04/2013
8Triglycerides (Triacylglycerol)IBA
02/2024 - 01/2008
8Analgesics (Analgesic Drugs)IBA
01/2024 - 01/2015
8Peptides (Polypeptides)IBA
10/2023 - 10/2007
8Long Noncoding RNAIBA
09/2023 - 01/2018
8Circular RNAIBA
05/2023 - 01/2019
8Small Interfering RNA (siRNA)IBA
08/2022 - 09/2007
8Transcription Factors (Transcription Factor)IBA
01/2022 - 05/2011
7Interleukin-6 (Interleukin 6)IBA
04/2024 - 05/2013
7VaccinesIBA
12/2023 - 09/2015
7Tyrosine Kinase InhibitorsIBA
09/2023 - 03/2012
7Reactive Oxygen Species (Oxygen Radicals)IBA
08/2023 - 06/2011
7UbiquitinIBA
03/2023 - 06/2011
7Troponin T (Troponin T1)IBA
10/2016 - 10/2014
6LipidsIBA
04/2024 - 01/2008
6AntigensIBA
10/2023 - 01/2014
6Oxygen (Dioxygen)IBA
07/2023 - 01/2016
6LigandsIBA
06/2023 - 03/2012
6CateninsIBA
04/2023 - 10/2012
6Apolipoproteins E (ApoE)IBA
01/2022 - 04/2015
6CollagenIBA
01/2022 - 04/2007
6DecitabineFDA Link
12/2017 - 01/2005
5Matrix Metalloproteinases (MMPs)IBA
05/2024 - 12/2009
5Estrogen ReceptorsIBA
05/2024 - 11/2008
5Polysaccharides (Glycans)IBA
01/2024 - 08/2009

Therapy/Procedure

107Therapeutics
05/2024 - 01/2006
35Drug Therapy (Chemotherapy)
05/2024 - 03/2006
22Immunotherapy
03/2024 - 09/2015
20Radiotherapy
01/2023 - 07/2009
10Transplantation
06/2024 - 10/2006
8Aftercare (After-Treatment)
12/2022 - 10/2011
8Peritoneal Dialysis
01/2020 - 07/2010
7Lung Transplantation
05/2024 - 08/2020
7Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 01/2017